- Home
- NCRA vs BRTX Comparison
NCRA vs BRTX Comparison
Compare NCRA & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- BRTX
- Stock Information
- Founded
- NCRA 2002
- BRTX 1997
- Country
- NCRA Taiwan
- BRTX United States
- Employees
- NCRA N/A
- BRTX N/A
- Industry
- NCRA Farming/Seeds/Milling
- BRTX Managed Health Care
- Sector
- NCRA Consumer Staples
- BRTX Health Care
- Exchange
- NCRA Nasdaq
- BRTX Nasdaq
- Market Cap
- NCRA 12.6M
- BRTX 11.3M
- IPO Year
- NCRA N/A
- BRTX N/A
- Fundamental
- Price
- NCRA $0.93
- BRTX $1.41
- Analyst Decision
- NCRA
- BRTX Strong Buy
- Analyst Count
- NCRA 0
- BRTX 1
- Target Price
- NCRA N/A
- BRTX $18.00
- AVG Volume (30 Days)
- NCRA 8.0K
- BRTX 100.5K
- Earning Date
- NCRA 08-14-2024
- BRTX 11-12-2024
- Dividend Yield
- NCRA N/A
- BRTX N/A
- EPS Growth
- NCRA N/A
- BRTX N/A
- EPS
- NCRA N/A
- BRTX N/A
- Revenue
- NCRA $20,483,694.00
- BRTX $377,000.00
- Revenue This Year
- NCRA N/A
- BRTX $482.76
- Revenue Next Year
- NCRA N/A
- BRTX $212.24
- P/E Ratio
- NCRA N/A
- BRTX N/A
- Revenue Growth
- NCRA N/A
- BRTX 189.55
- 52 Week Low
- NCRA $0.70
- BRTX $1.03
- 52 Week High
- NCRA $1.54
- BRTX $3.67
- Technical
- Relative Strength Index (RSI)
- NCRA 45.05
- BRTX 41.13
- Support Level
- NCRA $0.70
- BRTX $1.40
- Resistance Level
- NCRA $1.14
- BRTX $1.60
- Average True Range (ATR)
- NCRA 0.10
- BRTX 0.10
- MACD
- NCRA -0.01
- BRTX 0.00
- Stochastic Oscillator
- NCRA 51.40
- BRTX 42.86
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.